MATERIALS AND METHODS
Patients who underwent surgery for localized prostate cancer were included from the Turkish Urooncology Association (TUA) Prostate Cancer database. A History of previous treatment (radiotherapy or androgen deprivation therapy) or active surveillance (AS) were considered as exclusion criteria from the study. The date of prostate biopsy was regarded as the date of diagnosis and time to treatment was calculated as the number of days between the date of surgery and the diagnosis date. Patients were divided into two groups according the time period between the diagnosis and surgery; less than or equal to 90 days (group 1) or longer than 90 days (group 2). Surgical pathology results and oncological outcomes were compared between the two groups.